Andere talen Cleo Diagnostics Ltd

Aandelen

COV

AU0000288045

Beurs gesloten - Australian S.E. Andere beurzen 08:10:17 04-06-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
0,3 ^AUD	+25,00%		+76,47%	+71,43%

29/05	Onderzoek toont aan dat bloedtest van Cleo Diagnostics beter presteert dan klinische benchmarks	MT
02/04	Cleo gebruikt HcFocus voor markttoegang in de VS	MT

Andere talen

Krijg toegang tot al het nieuws: wees als eerste op de hoogte en reageer voordat de beurs dat doet!

Gratis inschrijven

Study Finds Cleo Diagnostics ' Blood Test Outperforms Clinical Benchmarks	29/05
Cleo Diagnostics Taps Lindus Health to Manage US Ovarian Cancer Clinical Trials	11/04
CLEO Taps HcFocus for US Market Entry	02/04
Cleo Diagnostics Concludes Design Transfer of Ovarian Cancer Detection Test Technology	12/02
50,000 Ordinary Shares of Cleo Diagnostics Ltd are subject to a Lock-Up Agreement Ending on 1-DEC-2023.	01/12
162,500 Ordinary Shares of Cleo Diagnostics Ltd are subject to a Lock-Up Agreement Ending on 30-NOV-2023.	30/11
Cleo Diagnostics Confirms Efficacy of Ovarian Cancer Test from Validation Study; Shares Surge 21%	06/11
50,000 Ordinary Shares of Cleo Diagnostics Ltd are subject to a Lock-Up Agreement Ending on 4-NOV-2023.	04/11
425,000 Ordinary Shares of Cleo Diagnostics Ltd are subject to a Lock-Up Agreement Ending on 21-OCT-2023.	21-10-23
75,000 Ordinary Shares of Cleo Diagnostics Ltd are subject to a Lock-Up Agreement Ending on 19-OCT-2023.	19-10-23
150,000 Ordinary Shares of Cleo Diagnostics Ltd are subject to a Lock-Up Agreement Ending on 18-OCT-2023.	18-10-23
100,000 Ordinary Shares of Cleo Diagnostics Ltd are subject to a Lock-Up Agreement Ending on 13-OCT-2023.	13-10-23
Cleo Diagnostics Advances Development of Cancer Test Kit	09-10-23
CLEO Diagnostics’ Chief Scientific Officer Move to Full-Time Arrangement	02-10-23
150,000 Ordinary Shares of Cleo Diagnostics Ltd are subject to a Lock-Up Agreement Ending on 30-SEP-2023.	30-09-23
125,000 Ordinary Shares of Cleo Diagnostics Ltd are subject to a Lock-Up Agreement Ending on 21-SEP-2023.	21-09-23
37,500 Ordinary Shares of Cleo Diagnostics Ltd are subject to a Lock-Up Agreement Ending on 19-SEP-2023.	19-09-23
CLEO Diagnostics Secures US Patent for Ovarian Cancer Biomarker Testing	22-08-23
Cleo Diagnostics Ltd has completed an IPO in the amount of AUD 12 million.	18-08-23
Cleo Diagnostics Ltd has filed an IPO in the amount of AUD 12 million.	23-06-23

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Cleo Diagnostics Ltd

Aandelen

COV

AU0000288045

Andere talen

Filters